Shin Nippon Biomedical Laboratories (SNBL) and Orient Bio Corporation (OBC) today announced that they have completed a transfer of assets related to the SNBL research animal quarantine/holding facility located in Alice, TX. Under this agreement all assets and operations related to this site will transfer to Orient Bio which will operate the site under the new name of Orient BioResource Center. Associated with this purchase agreement is an animal supply agreement that guarantees a continuation of the supply of high quality research animals to SNBL USA from the Orient BioResource Center.
“This important strategic decision will allow SNBL USA to concentrate fully on its core business of providing high quality and responsive preclinical services to our worldwide clients. We are also happy for our staff members at the Texas site for the new career opportunities that they will experience under Orient Bio”, stated Gary Jacobson, CEO and President of SNBL USA. For Orient Bio, the acquisition of the Alice, TX site and the entirety of its operations will be another extension of their already established network of companies related to the supply of laboratory animals and caging throughout Asia.
Tokyo, Japan and Everett, Washington – August 31, 2017